InsidersTradesSigma
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the full record of transactions filed by Dube Michael P. Director active across 1 company, notably Intellia Therapeutics, Inc.. Aggregated, 6 reports have been published. Breakdown: 0 buy · 4 sells. Total volume traded: €111k. Activity tracked since 1 July 2024. The latest transaction was disclosed on 1 July 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Dube Michael P is a declarant linked to Intellia Therapeutics, Inc., where he serves as VP, Chief Accounting Officer. He has 5 filings in total, and among the recent filings observed between 2024-07-03 and 2026-07-06, they show EUR 89842 of sales and EUR 0 of purchases, with the dominant transaction nature shown as sell.